熱門資訊> 正文

瑞思迈宣布CFO继任

2026-05-01 04:25

Resmed (RMD) chief financial officer Brett Sandercock will retire effective May 4, 2026.
Aaron Bloomer has been appointed CFO following a comprehensive search.
Bloomer joins from Exact Sciences, recently acquired by Abbott, where he served as CFO.
Sandercock will remain as an advisor to the CEO through the end of 2027.

More on ResMed

ResMed: Waiting For The Next Catalyst, Initiating With Hold Rating
ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell
ResMed Inc. 2026 Q2 - Results - Earnings Call Presentation
ResMed Q3 2026 Earnings Preview
Most oversold healthcare stocks above $10B on Wall Street amid Middle East disruptions

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。